CGT 3103
Alternative Names: CGT-3103; FGFR2-inhibitor; FGFR2-inhibitor-cogent bioscienceLatest Information Update: 28 Aug 2023
At a glance
- Originator Cogent Biosciences
- Class Antineoplastics; Small molecules
- Mechanism of Action Type-2 fibroblast growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer